Developer docs
API playgroundTry for free, no card

Search company profiles

Caldera Medical

Full company profile

uuid0007dn7

Namestring
Caldera Medical
Legal namestring
Caldera Medical, Inc
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Caldera Medical is a privately held women's health medical device company that develops, manufactures, and markets minimally invasive surgical products and devices for three core pelvic health conditions: Stress Urinary Incontinence (SUI), Pelvic Organ Prolapse (POP), and hysteroscopic tissue removal for uterine polyps and fibroids. The company's product portfolio includes the Desara family of mid-urethral slings (including Desara Blue SS and Desara TVez), the Vertessa line of POP implants with reusable introducers, the Benesta hysteroscopic tissue removal system, the LUMINELLE hysteroscopy and cystoscopy platform (acquired via UVision360 in October 2024), the INNOVO non-invasive pelvic floor strengthening device (acquired via Atlantic Therapeutics in September 2023), and the GYNECARE TVT family of products (acquired from Ethicon/Johnson & Johnson). Underlying technologies span surgical implant design, battery-powered hysteroscopic tissue morcellation with integrated visualization and tissue differentiation, high-resolution hysteroscopy optics, and electrical muscle stimulation for non-invasive pelvic floor therapy.

Caldera Medical generates revenue through hardware sales of medical devices to healthcare providers, primarily gynecologic surgeons and hospitals, using a multi-channel go-to-market model that combines direct field sales targeting specialist physicians, a global distributor network (Find Your Local Distributor program), and institutional access via group purchasing organizations, notably a national agreement with Premier Inc. covering approximately 4,350 U.S. hospitals. The company also operates the largest humanitarian program in women's health, which has treated over 400,000 women across 56 countries since 2016, serving both as a brand-building engine and as a channel for surgeon training and product adoption. With 51-100 employees and headquarters in Westlake Village, California (plus a European headquarters and innovation center in Galway, Ireland), the company is led by CEO and founder Bryon Merade and CFO John Pitstick, and pursues an active acquisition strategy to consolidate product lines and geographic reach in the women's pelvic health device market.

Short descriptiontext

Caldera Medical is a privately held women's health medical device company developing and marketing minimally invasive surgical and non-invasive devices for stress urinary incontinence, pelvic organ prolapse, and hysteroscopic tissue removal, sold to gynecologic surgeons, hospitals, and distributors globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWestlake Village, United States
HQ citystring
Westlake Village
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
women's pelvic health, stress urinary incontinence devices, pelvic organ prolapse implants, hysteroscopic tissue removal, surgical medical devices
Industry3 codes
PRIMARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKAJAE
Urogynecology & Pelvic Reconstructive Surgery (Female Pelvic Medicine)
SECONDARYHLAKAJAF
Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy)
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Women's Health Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Caldera Medical develops, manufactures, and markets surgical products for treating Stress Urinary Incontinence, Pelvic Organ Prolapse, polyps, and fibroids. Revenue is generated through direct sales to healthcare providers and distribution partnerships.

calderamedical.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Desara
Description

Line of surgical slings for stress urinary incontinence treatment, including Desara Blue SS, Desara TVez, and other sling products.

calderamedical.com
+4 more records
Core offering1 text field

Caldera Medical develops, manufactures, and markets minimally invasive medical devices for women's pelvic health, including surgical slings and implants for Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP), hysteroscopic tissue removal systems for uterine polyps and fibroids, and a non-invasive pelvic floor strengthening device. Products are sold to gynecologic surgeons and healthcare institutions through direct field sales, a national group purchasing agreement with Premier Inc., and a global distributor network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 87% of women were defined as dry after 12 weeks using INNOVO device
+4 more records
Product overview1 text field

Caldera Medical offers a portfolio of women's health medical devices focused on three main treatment areas: Stress Urinary Incontinence (SUI), Pelvic Organ Prolapse (POP), and hysteroscopic tissue removal for polyps and fibroids. The SUI portfolio includes the Desara family of slings (Desara Blue SS, Desara TVez), the GyneCare TVT family, and the non-invasive Innovo device acquired from Atlantic Therapeutics. The POP treatment solutions include Vertessa implants. For hysteroscopy, the company offers the Benesta tissue removal system and the LUMINELLE system acquired from UVision360. The products range from minimally invasive surgical implants to non-invasive devices, serving both office-based and surgical environments.

Product and service7 records
1Desara Blue SS Sling
CategoryStress Urinary Incontinence surgical sling
Description

Short suture mid-urethral sling for surgical treatment of Stress Urinary Incontinence, designed for transobturator (TOT) outside-in and suprapubic approaches. Features a reduced suture loop for easier tip attachment, unique blue mesh for enhanced intraoperative visibility, and compatibility with Suprapubic and TOT Outside-In introducers. Used by gynecologic surgeons for sling-based SUI repair.

2Desara TVez Sling System
CategoryStress Urinary Incontinence surgical sling
Description

FDA-cleared mid-urethral sling system for surgical treatment of Stress Urinary Incontinence with design improvements developed through physician collaboration to enhance ease of use and patient safety.

3Vertessa Pelvic Organ Prolapse Implants
CategoryPelvic Organ Prolapse implant
Description

Implant products for surgical treatment of pelvic organ prolapse (POP), featuring reusable introducers designed to reduce medical waste and lower SKU counts by at least 33%, delivering durable support for patients.

4Benesta Hysteroscopic Tissue Removal Family
CategoryHysteroscopic tissue removal device
Description

Flagship hysteroscopic tissue removal device for uterine polyp and fibroid removal. Features push-button hand activation, enlarged cutting window, built-in tissue differentiation technology for safety, state-of-the-art optics and illumination, and universal compatibility with all scopes and fluid management systems. Used by gynecologic surgeons for minimally invasive intrauterine procedures.

5LUMINELLE Hysteroscopy System
CategoryHysteroscopy / cystoscopy system
Description

High-resolution hysteroscopy and cystoscopy system for diagnostic and therapeutic procedures, with simplified workflow and novel LUMINELLE Bx on-demand biopsy technology featuring integrated visualization. Acquired via UVision360 in October 2024.

6INNOVO Pelvic Floor Strengthening System
CategoryNon-invasive pelvic floor therapy device
Description

FDA-cleared non-invasive pelvic floor strengthening and nerve stimulating device for first-line therapy treatment of Stress Urinary Incontinence. Uses electrical muscle stimulation in a wearable 'smart shorts' format to deliver 180 perfect Kegels in 30 minutes. Acquired from Atlantic Therapeutics in September 2023.

7GyneCare TVT Family
CategoryStress Urinary Incontinence surgical sling
Description

Mid-urethral sling products for surgical treatment of Stress Urinary Incontinence, acquired from Ethicon (J&J) and integrated into Caldera Medical's expanded SUI surgical portfolio.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-09-06
Description

Acquired Atlantic Therapeutics, an Ireland-based provider of non-invasive pelvic floor strengthening and nerve stimulating solutions for women. The acquisition adds the commercial leading non-invasive, FDA-cleared INNOVO product family as a first-line therapy for women with stress urinary incontinence. Caldera Medical maintains European headquarters and innovation center in Galway, Ireland.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Minerva Surgical
TypeDirect peer
Description

Minerva Surgical directly competes with Caldera's Benesta hysteroscopic tissue removal device in the treatment of uterine polyps and fibroids with a similar office- and OR-based tissue removal platform.

2Axonics
TypeDirect peer
Description

Axonics offers sacral neuromodulation for urinary incontinence as a non-mesh alternative to Caldera's sling portfolio; both target the same SUI patient population but via different mechanisms, making Axonics a relevant competitor for first-line therapy decisions.

TypeDirect peer
Description

ConvaTec operates a continence care portfolio that competes with Caldera's INNOVO non-invasive SUI device and shares the same women with stress urinary incontinence patient population.

TypeDirect peer
Description

Boston Scientific competes directly with Caldera in pelvic floor repair (mesh and biologic implants) and surgical SUI solutions through its Women's Health portfolio, and operates at meaningfully larger scale.

TypeDirect peer
Description

Coloplast is a direct competitor in surgical SUI and pelvic organ prolapse treatment through its AttaSeal and Altis sling systems, as well as a leading continence care portfolio that overlaps with Caldera's INNOVO non-invasive therapy.

TypeDirect peer
Description

Hologic's MyoSure hysteroscopic tissue removal system is a direct competitor to Caldera's Benesta family for polyp and fibroid removal, and Hologic is a major player in women's health minimally invasive gynecology.

TypeEmerging player
Description

Renovia is an emerging digital therapeutics company developing connected pelvic floor training devices for female SUI, providing partial overlap with Caldera's INNOVO non-invasive first-line therapy positioning.

TypeBroad incumbent
Description

Medtronic's InterStim sacral neuromodulation system is a major non-mesh alternative for SUI and overactive bladder, making Medtronic a broad incumbent competitor for incontinence patient treatment decisions even though it does not specialize in women's pelvic health.

TypeDirect peer
Description

Laborie is a private medical device company focused on urology and pelvic health diagnostics and therapeutics, with products including urodynamic systems and incontinence therapies that overlap with Caldera's pelvic health focus.

TypeDirect peer
Description

CooperSurgical operates broadly in women's health including hysteroscopy systems and pelvic floor products that compete with multiple Caldera lines, including hysteroscopy and surgical SUI/POP solutions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Caldera Medical

Women's Health Medical Devicescalderamedical.com

Caldera Medical is a privately held women's health medical device company developing and marketing minimally invasive surgical and non-invasive devices for stress urinary incontinence, pelvic organ prolapse, and hysteroscopic tissue removal, sold to gynecologic surgeons, hospitals, and distributors globally.

What Caldera Medical does

Caldera Medical is a privately held women's health medical device company that develops, manufactures, and markets minimally invasive surgical products and devices for three core pelvic health conditions: Stress Urinary Incontinence (SUI), Pelvic Organ Prolapse (POP), and hysteroscopic tissue removal for uterine polyps and fibroids. The company's product portfolio includes the Desara family of mid-urethral slings (including Desara Blue SS and Desara TVez), the Vertessa line of POP implants with reusable introducers, the Benesta hysteroscopic tissue removal system, the LUMINELLE hysteroscopy and cystoscopy platform (acquired via UVision360 in October 2024), the INNOVO non-invasive pelvic floor strengthening device (acquired via Atlantic Therapeutics in September 2023), and the GYNECARE TVT family of products (acquired from Ethicon/Johnson & Johnson). Underlying technologies span surgical implant design, battery-powered hysteroscopic tissue morcellation with integrated visualization and tissue differentiation, high-resolution hysteroscopy optics, and electrical muscle stimulation for non-invasive pelvic floor therapy.

Caldera Medical generates revenue through hardware sales of medical devices to healthcare providers, primarily gynecologic surgeons and hospitals, using a multi-channel go-to-market model that combines direct field sales targeting specialist physicians, a global distributor network (Find Your Local Distributor program), and institutional access via group purchasing organizations, notably a national agreement with Premier Inc. covering approximately 4,350 U.S. hospitals. The company also operates the largest humanitarian program in women's health, which has treated over 400,000 women across 56 countries since 2016, serving both as a brand-building engine and as a channel for surgeon training and product adoption. With 51-100 employees and headquarters in Westlake Village, California (plus a European headquarters and innovation center in Galway, Ireland), the company is led by CEO and founder Bryon Merade and CFO John Pitstick, and pursues an active acquisition strategy to consolidate product lines and geographic reach in the women's pelvic health device market.

Caldera Medical firmographics

Firmographics
Name
Caldera Medical
Legal name
Caldera Medical, Inc
Website
https://calderamedical.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
101–250 employees
Short description
Caldera Medical is a privately held women's health medical device company developing and marketing minimally invasive surgical and non-invasive devices for stress urinary incontinence, pelvic organ prolapse, and hysteroscopic tissue removal, sold to gynecologic surgeons, hospitals, and distributors globally.
Ownership category
akta.pro rank

Caldera Medical industry classification

Industry
Product category
Women's Health Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKAJAE
Urogynecology & Pelvic Reconstructive Surgery (Female Pelvic Medicine)
SECONDARYHLAKAJAF
Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy)

Keywords

  • Women's pelvic health
  • Stress urinary incontinence devices
  • Pelvic organ prolapse implants
  • Hysteroscopic tissue removal
  • Surgical medical devices

Where Caldera Medical is headquartered

Location

Headquarters

HQ city
Westlake Village
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Caldera Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Medical Device Sales: Caldera Medical develops, manufactures, and markets surgical products for treating Stress Urinary Incontinence, Pelvic Organ Prolapse, polyps, and fibroids. Revenue is generated through direct sales to healthcare providers and distribution partnerships.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Caldera Medical product offering

Product offering

Core offering

Caldera Medical develops, manufactures, and markets minimally invasive medical devices for women's pelvic health, including surgical slings and implants for Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP), hysteroscopic tissue removal systems for uterine polyps and fibroids, and a non-invasive pelvic floor strengthening device. Products are sold to gynecologic surgeons and healthcare institutions through direct field sales, a national group purchasing agreement with Premier Inc., and a global distributor network.

Product overview

Caldera Medical offers a portfolio of women's health medical devices focused on three main treatment areas: Stress Urinary Incontinence (SUI), Pelvic Organ Prolapse (POP), and hysteroscopic tissue removal for polyps and fibroids. The SUI portfolio includes the Desara family of slings (Desara Blue SS, Desara TVez), the GyneCare TVT family, and the non-invasive Innovo device acquired from Atlantic Therapeutics. The POP treatment solutions include Vertessa implants. For hysteroscopy, the company offers the Benesta tissue removal system and the LUMINELLE system acquired from UVision360. The products range from minimally invasive surgical implants to non-invasive devices, serving both office-based and surgical environments.

Differentiator

Problem solved

Functional benefit

Brands

  • Desara: Line of surgical slings for stress urinary incontinence treatment, including Desara Blue SS, Desara TVez, and other sling products.
  • Vertessa
  • Benesta
  • LUMINELLE
  • Innovo

Products and services

  • Desara Blue SS Sling Short suture mid-urethral sling for surgical treatment of Stress Urinary Incontinence, designed for transobturator (TOT) outside-in and suprapubic approaches. Features a reduced suture loop for easier tip attachment, unique blue mesh for enhanced intraoperative visibility, and compatibility with Suprapubic and TOT Outside-In introducers. Used by gynecologic surgeons for sling-based SUI repair.
  • Desara TVez Sling System FDA-cleared mid-urethral sling system for surgical treatment of Stress Urinary Incontinence with design improvements developed through physician collaboration to enhance ease of use and patient safety.
  • Vertessa Pelvic Organ Prolapse Implants Implant products for surgical treatment of pelvic organ prolapse (POP), featuring reusable introducers designed to reduce medical waste and lower SKU counts by at least 33%, delivering durable support for patients.
  • Benesta Hysteroscopic Tissue Removal Family Flagship hysteroscopic tissue removal device for uterine polyp and fibroid removal. Features push-button hand activation, enlarged cutting window, built-in tissue differentiation technology for safety, state-of-the-art optics and illumination, and universal compatibility with all scopes and fluid management systems. Used by gynecologic surgeons for minimally invasive intrauterine procedures.
  • LUMINELLE Hysteroscopy System High-resolution hysteroscopy and cystoscopy system for diagnostic and therapeutic procedures, with simplified workflow and novel LUMINELLE Bx on-demand biopsy technology featuring integrated visualization. Acquired via UVision360 in October 2024.
  • INNOVO Pelvic Floor Strengthening System FDA-cleared non-invasive pelvic floor strengthening and nerve stimulating device for first-line therapy treatment of Stress Urinary Incontinence. Uses electrical muscle stimulation in a wearable 'smart shorts' format to deliver 180 perfect Kegels in 30 minutes. Acquired from Atlantic Therapeutics in September 2023.
  • GyneCare TVT Family Mid-urethral sling products for surgical treatment of Stress Urinary Incontinence, acquired from Ethicon (J&J) and integrated into Caldera Medical's expanded SUI surgical portfolio.

Quantifiable outcome

  • 87% of women were defined as dry after 12 weeks using INNOVO device
  • +4 more outcomes

Companies that use Caldera Medical

Customer profile

Named customers2 records

Segments5 records

Ideal customer profiles3 records

Caldera Medical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Caldera Medical partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Atlantic TherapeuticscoreStrategic or Co-development Partner · 6 September 2023Acquired Atlantic Therapeutics, an Ireland-based provider of non-invasive pelvic floor strengthening and nerve stimulating solutions for women. The acquisition adds the commercial leading non-invasive, FDA-cleared INNOVO product family as a first-line therapy for women with stress urinary incontinence. Caldera Medical maintains European headquarters and innovation center in Galway, Ireland.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Caldera Medical competitors and assessment

Company assessment

Direct peers

  • Minerva Surgical: Minerva Surgical directly competes with Caldera's Benesta hysteroscopic tissue removal device in the treatment of uterine polyps and fibroids with a similar office- and OR-based tissue removal platform.
  • Axonics: Axonics offers sacral neuromodulation for urinary incontinence as a non-mesh alternative to Caldera's sling portfolio; both target the same SUI patient population but via different mechanisms, making Axonics a relevant competitor for first-line therapy decisions.
  • ConvaTec: ConvaTec operates a continence care portfolio that competes with Caldera's INNOVO non-invasive SUI device and shares the same women with stress urinary incontinence patient population.
  • Boston Scientific: Boston Scientific competes directly with Caldera in pelvic floor repair (mesh and biologic implants) and surgical SUI solutions through its Women's Health portfolio, and operates at meaningfully larger scale.
  • Coloplast: Coloplast is a direct competitor in surgical SUI and pelvic organ prolapse treatment through its AttaSeal and Altis sling systems, as well as a leading continence care portfolio that overlaps with Caldera's INNOVO non-invasive therapy.
  • Hologic: Hologic's MyoSure hysteroscopic tissue removal system is a direct competitor to Caldera's Benesta family for polyp and fibroid removal, and Hologic is a major player in women's health minimally invasive gynecology.
  • Laborie Medical Technologies: Laborie is a private medical device company focused on urology and pelvic health diagnostics and therapeutics, with products including urodynamic systems and incontinence therapies that overlap with Caldera's pelvic health focus.
  • CooperSurgical: CooperSurgical operates broadly in women's health including hysteroscopy systems and pelvic floor products that compete with multiple Caldera lines, including hysteroscopy and surgical SUI/POP solutions.

Emerging players

  • Renovia: Renovia is an emerging digital therapeutics company developing connected pelvic floor training devices for female SUI, providing partial overlap with Caldera's INNOVO non-invasive first-line therapy positioning.

Broad incumbents

  • Medtronic: Medtronic's InterStim sacral neuromodulation system is a major non-mesh alternative for SUI and overactive bladder, making Medtronic a broad incumbent competitor for incontinence patient treatment decisions even though it does not specialize in women's pelvic health.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Caldera Medical social profiles

Digital presence

Caldera Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Caldera Medical leadership team

Management profile

Number of profiles

Profiles4 records

Caldera Medical subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Caldera Medical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Caldera Medical M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Caldera Medical

What does Caldera Medical do?

Caldera Medical develops, manufactures, and markets minimally invasive medical devices for women's pelvic health, including surgical slings and implants for Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP), hysteroscopic tissue removal systems for uterine polyps and fibroids, and a non-invasive pelvic floor strengthening device. Products are sold to gynecologic surgeons and healthcare institutions through direct field sales, a national group purchasing agreement with Premier Inc., and a global distributor network.

Is Caldera Medical a public or private company?

Caldera Medical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Caldera Medical founded?

Caldera Medical was founded in 2002. It employs 101 to 250 people.

Where is Caldera Medical based?

Caldera Medical is headquartered in Westlake Village, United States, in the North America region.

How does Caldera Medical make money?

One revenue line is on record: medical Device Sales.

Who are Caldera Medical's main competitors?

Direct peers on record are Minerva Surgical, Axonics, ConvaTec, Boston Scientific, Coloplast, Hologic, Laborie Medical Technologies and CooperSurgical. Renovia is listed as an emerging player. Medtronic is listed as a broad incumbent.

Does Caldera Medical have an API?

No public API is recorded for Caldera Medical.

What industry is Caldera Medical in?

Caldera Medical's product category is Women's Health Medical Devices. Its primary akta.pro industry code is HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS), with a secondary code of HLAKAJAE, Urogynecology & Pelvic Reconstructive Surgery (Female Pelvic Medicine). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FortunebusinessinsightsFemale Stress Urinary Incontinence Treatment Devices Market Size, 2034A market research report projects growth in the global Female Stress Urinary Incontinence Treatment Devices Market through 2034, driven by rising disease prevalence (15.7% of adult women in the U.S. affected) and increasing adoption of non-invasive treatment devices. Key industry developments include Boston Scientific Corporation's acquisition of Axonics, Inc. in January 2024 and Caldera Medical, Inc.'s acquisition of Atlantic Therapeutics in September 2023, alongside FDA clearances for new devices. The North American region dominated the market in 2023 due to advanced healthcare infrastructure and high patient awareness.Market ScoopFemale Stress Urinary Incontinence Treatment Device MarketThe global female stress urinary incontinence treatment device market is projected to grow from US$ 815.2 million in 2024 to US$ 1,501.7 million by 2034, at a 6.3% CAGR, driven by rising prevalence of pelvic floor disorders and demand for minimally invasive solutions. In January 2024, Boston Scientific Corporation completed its acquisition of Axonics, Inc. to strengthen its neuromodulation bladder therapy portfolio, while in September 2023 Caldera Medical finalized its acquisition of Atlantic Therapeutics to expand non-invasive treatment options. Medtronic secured U.S. regulatory authorization for its Altaviva neuromodulation system in September 2025, offering patients a non-pharmacological alternative for urinary incontinence management.Mpo-magCaldera Medical Acquires J&J MedTech’s Gynecare TVT ProductsCaldera Medical acquired Johnson & Johnson MedTech's Gynecare TVT product line for treating stress urinary incontinence. The acquisition includes TVT, TVT Exact, TVT-O, and TVT Abbrevo, with over two decades of clinical data. Caldera will keep the same manufacturing facility and expand global customer support.AETOSWireCaldera Medical's Humanitarian Effort Reaches New Heights: 400,000 Women Treated WorldwideCaldera Medical's humanitarian program has treated over 400,000 women across 296 missions in 56 countries since 2016. The company has trained over 600 surgeons and aims to aid one million women by 2027.KnobbeWomen’s Health Medical Device Company Caldera Medical Acquires UVision 360Caldera Medical, a women's health medical device company, has acquired UVision 360. The acquisition represents a strategic expansion for Caldera Medical into new technological capabilities within the healthcare sector. This transaction signifies growth and diversification for the acquiring entity.Business Wire BlogCaldera Medical Acquires UVision360 and the LUMINELLE Product Family, Expanding Minimally Invasive Hysteroscopy PortfolioCaldera Medical acquired UVision360, the developer of the LUMINELLE hysteroscopy and cystoscopy systems. The acquisition expands Caldera's minimally invasive hysteroscopy portfolio for diagnosing and treating polyps, fibroids, and intrauterine pathology. The LUMINELLE system offers high-resolution optics and on-demand biopsy technology.AETOSWireCaldera Medical Acquires Ethicon’s GYNECARE TVT™ Family of Products in Transformational Expansion Globally for Women’s Health CompanyCaldera Medical acquired Ethicon's GYNECARE TVT family of products for women's health, including TVT, TVT Exact, TVT-O, and TVT Abbrevo. The company will transition the products in coming months, maintaining the same manufacturing facility and team. The acquisition follows prior purchases of Atlantic Therapeutics and UVision360.Mpo-magCaldera Medical Acquires Atlantic TherapeuticsCaldera Medical completed the acquisition of Atlantic Therapeutics, an Ireland-based provider of non-invasive pelvic floor devices. The deal adds Atlantic's FDA-cleared Innovo products, a first-line therapy for stress urinary incontinence, to Caldera's portfolio. The acquisition aims to scale Innovo globally and expand Caldera's solution suite.CalderamedicalCaldera Medical Acquires Atlantic Therapeutics to Expand Portfolio in Women’s HealthCaldera Medical completed its acquisition of Atlantic Therapeutics, an Ireland-based provider of non-invasive pelvic floor strengthening solutions. This transaction adds the Innovo product family to Caldera Medical's portfolio, allowing for global scaling of the technology. The companies will maintain a European headquarters and innovation center in Galway, Ireland.Medical Device and Diagnostic industryCaldera Medical Completes Acquisition of Atlantic TherapeuticsCaldera Medical, a women's health device company, announced the completion of its acquisition of Atlantic Therapeutics, an Irish provider of non-invasive pelvic floor strengthening and nerve stimulation solutions. Caldera adds Atlantic's FDA-cleared Innovo at-home device, priced at €399, to its portfolio of Desara, Vertessa Lite and Benesta products. Caldera will keep its European headquarters and innovation center in Galway, Ireland.